Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

Background and objectives: Sevelamer carbonate is an improved, buffered form of sevelamer hydrochloride developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. This study investigated the ability of sevelamer carbonate to control serum phosphorous in hyperphosphatem...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ketteler, Markus, Rix, Marianne, Fan, Stanley, Pritchard, Nicholas, Oestergaard, Ove, Chasan-Taber, Scott, Heaton, Jeremy, Duggal, Ajay, Kalra, Philip A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2008
Pynciau:
Mineral Metabolism/Bone Disease
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2440270/
https://ncbi.nlm.nih.gov/pubmed/18450923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05161107
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg